17 April 2025
17 April 2025
Despite major product launches from diabetes rivals last year, Abbott’s diabetes unit brought in $1.8bn total Q1 sales to kickstart the year.
Blocked from discussing new research, Dr Kevin Hall said he doubted if he could continue to freely conduct ‘unbiased science’ at the NIH.
The company anticipates that the introduction of Verafeye, with its 4D imaging provision, will usher in a ‘new era’ of intracardiac imaging.
GeneDx is set to pay Fabric Genomics an aggregate of up to $33m in cash at the time of closure.
The approval adds to the test’s existing CE Mark certification granted by the European Union in 2014.
Coronary stenting has become a standard clinical approach for managing CAD and ACS.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
